Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.
about
Lost in translation: pluripotent stem cell-derived hematopoiesisProgress and obstacles towards generating hematopoietic stem cells from pluripotent stem cellsInduced pluripotent stem cells in hematology: current and future applicationsDefinitive Hematopoietic Multipotent Progenitor Cells Are Transiently Generated From Hemogenic Endothelial Cells in Human Pluripotent Stem Cells.Inhibition of β-catenin signaling respecifies anterior-like endothelium into beating human cardiomyocytes.Transcriptional diversity during lineage commitment of human blood progenitors.Generation of X-CGD cells for vector evaluation from healthy donor CD34(+) HSCs by shRNA-mediated knock down of gp91(phox).Development of hematopoietic stem and progenitor cells from human pluripotent stem cells.Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis.Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point MutationTargeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells.From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantationGraphene Oxide promotes embryonic stem cell differentiation to haematopoietic lineage.Molecular Analysis of Neutrophil Differentiation from Human Induced Pluripotent Stem Cells Delineates the Kinetics of Key Regulators of Hematopoiesis.Enforced Expression of HOXB4 in Human Embryonic Stem Cells Enhances the Production of Hematopoietic Progenitors but Has No Effect on the Maturation of Red Blood Cells.Medial HOXA genes demarcate haematopoietic stem cell fate during human development.Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional Defects.Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells.A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells.Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal ProgenitorsGeneration of hematopoietic stem cells from human embryonic stem cells using a defined, stepwise, serum-free, and serum replacement-free monolayer culture method.Cell therapies for treatment of human immunodeficiency virus infection.Modulation of Hematopoietic Lineage Specification Impacts TREM2 Expression in Microglia-Like Cells Derived From Human Stem CellsTargeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction.Use of genome-editing tools to treat sickle cell disease.Development of autologous blood cell therapies.Generating human hematopoietic stem cells in vitro -exploring endothelial to hematopoietic transition as a portal for stemness acquisition.Origin of the hematopoietic system in the human embryo.Progress towards generation of human haematopoietic stem cells.A view of human haematopoietic development from the Petri dish.Induced Pluripotent Stem Cell for the Study and Treatment of Sickle Cell Anemia.Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential.In vivo repopulating activity emerges at the onset of hematopoietic specification during embryonic stem cell differentiation.Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next Frontier.A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.The role of Wnt signaling in hematopoietic stem cell development.A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1.RUNX1c Regulates Hematopoietic Differentiation of Human Pluripotent Stem Cells Possibly in Cooperation with Proinflammatory Signaling.WNT9A Is a Conserved Regulator of Hematopoietic Stem and Progenitor Cell Development.
P2860
Q26801840-537AFB4A-AC9F-4B2D-BF1C-CD559E9A2329Q26824479-E13ADB6E-34E8-4798-BF17-F30D2DCE022CQ27016090-16787B7C-67AD-4391-B761-EEB4E335522CQ27334325-E1B01BDF-0056-44C7-A13A-4B8F08092447Q27345392-01B9BF5C-B54E-4117-AFF8-F5E27D51D758Q34626417-D091D0F4-ADE6-4FAA-A8D7-66DF26E10F8AQ35184193-56A394BD-096E-4D7E-9DAE-79B3AB24A42DQ35676075-6ECB51C0-5A8F-437B-BE12-1893A97F2F06Q35878866-E85D9810-C91F-4784-A66A-9E526572A857Q36236565-A86EEBCF-D28B-4132-B7AC-C8C9B3564076Q36450196-2EB4580B-10F1-4982-9356-E35D67B4D6D4Q36756725-F1FC99F1-001D-4CEB-AB82-98C131BFF6B4Q36879075-0D205C42-0B82-4925-ADE6-0A834FBB38C9Q36919097-B39593EA-B8E2-444A-9678-728DF75BE050Q36968311-5758F635-0AF6-4EB9-BC23-1BE6B9CC7807Q37111916-71A06D89-716E-4970-A366-714A9566EB44Q37168069-3BBE30E8-D7E0-48CA-9818-4597DFB8161FQ37171312-C7CB9B8A-E29E-430E-BDC4-A11F69B37662Q37214753-8C4D6D28-9CDC-41A1-A162-4C9F9B6C334EQ37299126-F741D0D5-5D04-4403-B338-32D8380E50DAQ37313864-62BAC24D-C74B-4E93-B7F5-6C977FE4359AQ37740413-2DBF06F2-C409-4B09-B20C-A6B9E49169A7Q38366376-2429E11A-5697-4F40-8009-7285A27139D8Q38690794-DBF81F99-0C46-4157-BC65-2A6B0D00D56FQ38718308-258DB40C-DE4C-4F48-9A18-D975550659A2Q38850483-87BB9E5D-EB09-4442-B0D3-6226113E686CQ38877308-1327EFF3-8A0B-4AF6-BC8B-CA4D0EE27E51Q38890095-49B2A755-1A98-409E-B3C9-88D6D71B3406Q38946889-0FC7BE7F-5EF3-49A8-89D1-13B094BBC701Q38977109-2AA03440-CAAA-4ABE-9DA2-125754209C97Q39017189-50232D7E-E14A-4CF2-84CC-9B977B1B3070Q41320530-5037EC8F-A41D-482F-9F18-12752082D337Q42046446-0F9FC2D8-0FAC-4F48-ABEF-823BB1ACD222Q42683851-8D14807D-1521-45A4-AF4F-9A375BA8C04FQ45874318-4A103F04-113D-4417-8258-68DD0D7A5059Q45874858-E6BF9125-5BD5-4EC9-8A7F-CFD9888F6EA9Q45971479-2656DE12-407D-42B3-A5EB-FD9B0FABF482Q47207770-A0B3055D-119F-4B9C-A377-EC558171FD56Q48133179-6A8FCFC5-FF70-48E0-8559-960042AB2D04Q48140387-908A7F40-F567-47AE-A22C-49E34138B117
P2860
Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Hematopoietic specification fr ...... on of hematopoietic stem cells
@nl
Hematopoietic specification fr ...... n of hematopoietic stem cells.
@ast
Hematopoietic specification fr ...... n of hematopoietic stem cells.
@en
type
label
Hematopoietic specification fr ...... on of hematopoietic stem cells
@nl
Hematopoietic specification fr ...... n of hematopoietic stem cells.
@ast
Hematopoietic specification fr ...... n of hematopoietic stem cells.
@en
prefLabel
Hematopoietic specification fr ...... on of hematopoietic stem cells
@nl
Hematopoietic specification fr ...... n of hematopoietic stem cells.
@ast
Hematopoietic specification fr ...... n of hematopoietic stem cells.
@en
P2860
P3181
P1433
P1476
Hematopoietic specification fr ...... n of hematopoietic stem cells.
@en
P2093
Igor I Slukvin
P2860
P304
P3181
P356
10.1182/BLOOD-2013-07-474825
P407
P577
2013-10-11T00:00:00Z